Botox® Injection Therapy for Chronic Migraine
Chronic migraine is more than “just a headache”. It is debilitating, isolating, exhausting. It takes away your days. Quality of life. Freedom. And often it is resistant to pills, injections, or alternative methods.
The good news: Botox® is an officially approved migraine therapy – scientifically proven, gentle in application, and often highly effective. At BONITAS we perform the treatment with precision and personal care – for everyone who wants to reclaim a life free from pain
At a glance: Chronic migraine can be significantly reduced with Botox following the PREEMPT protocol (a medically indicated treatment).
- Treatment time: 20–30 minutes
- Method: botulinum toxin following the PREEMPT protocol (31 points)
- Indication: chronic migraine (>15 days/month)
- Onset of effect: after 2–4 weeks
- Duration of effect: 3 months, repeat treatment recommended
- Prices: in our price overview
How does Botox® work for migraines?
Botulinum toxin (Botox®) blocks the release of pain messengers at the nerve endings. This leads to:
This means: fewer attacks, shorter duration, lower intensity – often from the first treatment.
Who is a candidate for migraine treatment with Botox®?
BONITAS checks in a detailed consultation whether you are medically suitable for Botox migraine treatment – and develops a clear treatment plan.
How the treatment at BONITAS works
The injection is performed with very fine needles – almost painless. BONITAS ensures a relaxed, calm atmosphere.
Effects & Results
First effects noticeable after 7–14 days, the full effect usually after 2–3 treatments.
Advantages over classic therapy
Botox®
Medications
Why BONITAS?
BONITAS combines medical knowledge with genuine care – for a result that you not only feel, but can finally live again.
Frequently asked questions (FAQ)
If you are considering medical aesthetic treatment, schedule your consultation for an honest assessment tailored to your needs.
Scientific References
- Dodick DW et al. „OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.“ Headache. 2010. PubMed PMID 20487038
- Lanteri-Minet M et al. „Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data.“ Cephalalgia. 2022. PubMed PMID 36081276
- Ornello R et al. „Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study.“ Pain and Therapy. 2021. PubMed PMID 33778933
- Frank F et al. „CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis.“ Cephalalgia. 2021. PubMed PMID 34130525
Medically reviewed and written by Alejandro Martí
Specialist in Plastic and Aesthetic Surgery 🇩🇪 🇪🇸 · Consulting surgeon
With more than 1,000 plastic and aesthetic treatments performed, both surgical and minimally invasive. Comes from a family with a long tradition in Plastic and Aesthetic Surgery.
Last reviewed: May 2026